173 related articles for article (PubMed ID: 26542149)
1. The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane.
Grassi S; Prioni S; Cabitta L; Aureli M; Sonnino S; Prinetti A
Neurochem Res; 2016 Feb; 41(1-2):130-43. PubMed ID: 26542149
[TBL] [Abstract][Full Text] [Related]
2. Adult-onset depletion of sulfatide leads to axonal degeneration with relative myelin sparing.
Dustin E; McQuiston AR; Honke K; Palavicini JP; Han X; Dupree JL
Glia; 2023 Sep; 71(9):2285-2303. PubMed ID: 37283058
[TBL] [Abstract][Full Text] [Related]
3. Differential binding patterns of anti-sulfatide antibodies to glial membranes.
Meehan GR; McGonigal R; Cunningham ME; Wang Y; Barrie JA; Halstead SK; Gourlay D; Yao D; Willison HJ
J Neuroimmunol; 2018 Oct; 323():28-35. PubMed ID: 30196830
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism.
Takahashi H; Perez-Canamas A; Ye H; Han X; Strittmatter SM
bioRxiv; 2023 Sep; ():. PubMed ID: 37745346
[TBL] [Abstract][Full Text] [Related]
5. Chronic brain damage in HIV-infected individuals under antiretroviral therapy is associated with viral reservoirs, sulfatide release, and compromised cell-to-cell communication.
D'Amico D; Barone R; Di Felice V; Ances B; Prideaux B; Eugenin EA
Cell Mol Life Sci; 2023 Apr; 80(4):116. PubMed ID: 37016051
[TBL] [Abstract][Full Text] [Related]
6. The impact of sulfatide loss on the progress of Alzheimer's disease.
Finkielstein CV; Capelluto DGS
Clin Transl Discov; 2023 Aug; 3(4):. PubMed ID: 38463462
[No Abstract] [Full Text] [Related]
7. Myelin lipid deficiency: a new key driver of Alzheimer's disease.
Qiu S; Palavicini JP; Han X
Neural Regen Res; 2023 Jan; 18(1):121-122. PubMed ID: 35799524
[No Abstract] [Full Text] [Related]
8. Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration.
Lopez Juarez A; He D; Richard Lu Q
Brain Res; 2016 May; 1638(Pt B):209-220. PubMed ID: 26546966
[TBL] [Abstract][Full Text] [Related]
9. Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology.
Di Pauli F; Höftberger R; Reindl M; Beer R; Rhomberg P; Schanda K; Sato D; Fujihara K; Lassmann H; Schmutzhard E; Berger T
Neurol Neuroimmunol Neuroinflamm; 2015 Dec; 2(6):e175. PubMed ID: 26587556
[TBL] [Abstract][Full Text] [Related]
10. Self-reactive CD4(+) T cells activated during viral-induced demyelination do not prevent clinical recovery.
Savarin C; Bergmann CC; Gaignage M; Stohlman SA
J Neuroinflammation; 2015 Nov; 12():207. PubMed ID: 26559484
[TBL] [Abstract][Full Text] [Related]
11. Isolation and Analysis of Detergent-Resistant Membrane Fractions.
Aureli M; Grassi S; Sonnino S; Prinetti A
Methods Mol Biol; 2016; 1376():107-31. PubMed ID: 26552679
[TBL] [Abstract][Full Text] [Related]
12. Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders.
Shim G; Romero-Morales AI; Sripathy SR; Maher BJ
Front Cell Neurosci; 2023; 17():1322813. PubMed ID: 38273973
[TBL] [Abstract][Full Text] [Related]
13. Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy.
Farah MH; Dali CÍ; Groeschel S; Moldovan M; Whiteman DAH; Malanga CJ; Krägeloh-Mann I; Li J; Barton N; Krarup C
Ann Clin Transl Neurol; 2024 Feb; 11(2):328-341. PubMed ID: 38146590
[TBL] [Abstract][Full Text] [Related]
14. Compromised Myelin and Axonal Molecular Organization Following Adult-Onset Sulfatide Depletion.
Dustin E; Suarez-Pozos E; Stotesberry C; Qiu S; Palavicini JP; Han X; Dupree JL
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239102
[TBL] [Abstract][Full Text] [Related]
15. Fatty Acid 2-Hydroxylase and 2-Hydroxylated Sphingolipids: Metabolism and Function in Health and Diseases.
Eckhardt M
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902339
[TBL] [Abstract][Full Text] [Related]
16. Thermotropic Behavior and Structural Organization of C24:1 Sulfatide Dispersions and Its Mixtures with Cationic Bilayers.
de Andrade L; Duarte EL; Lamy MT; Rozenfeld JHK
ACS Omega; 2023 Feb; 8(6):5306-5315. PubMed ID: 36816677
[TBL] [Abstract][Full Text] [Related]
17. Identification of the Lipid Antigens Recognized by rHIgM22, a Remyelination-Promoting Antibody.
Grassi S; Cabitta L; Prioni S; Mauri L; Ciampa MG; Yokoyama N; Iwabuchi K; Zorina Y; Prinetti A
Neurochem Res; 2023 Jun; 48(6):1783-1797. PubMed ID: 36695984
[TBL] [Abstract][Full Text] [Related]
18. Sulfatide Deficiency, an Early Alzheimer's Lipidomic Signature, Causes Brain Ventricular Enlargement in the Absence of Classical Neuropathological Hallmarks.
Palavicini JP; Ding L; Pan M; Qiu S; Wang H; Shen Q; Dupree JL; Han X
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613677
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
